Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic | Zendy

J Ryan Bariola | Zendy; Erin K McCreary | Zendy; Tina Khadem | Zendy; Graham M. Snyder | Zendy; Richard J. Wadas | Zendy; David A. Nace | Zendy; Douglas B. White | Zendy; Donald M. Yealy | Zendy; Mark Schmidhofer | Zendy

Open Access

Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic

Author(s) -

J Ryan Bariola,

Erin K McCreary,

Tina Khadem,

Graham M. Snyder,

Richard J. Wadas,

David A. Nace,

Douglas B. White,

Donald M. Yealy,

Mark Schmidhofer

Publication year - 2021

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofab151

Subject(s) - covid-19 , medicine , pandemic , monoclonal antibody , virology , coronavirus , distribution (mathematics) , antibody , disease , infectious disease (medical specialty) , immunology , outbreak , mathematical analysis , mathematics

Emergency authorized coronavirus disease 2019 (COVID-19)–neutralizing monoclonal antibodies can aid outpatients with mild to moderate COVID-19 infection. Many report barriers to adequate distribution and uptake. We present our model for distribution in a large health system as well as early lessons learned.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research